Back to Search
STEPHEN ANSELL, M.D.
M.D.
Hematology (Internal Medicine) Physician
NPI: 1558335935IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
38954(MN)
CMS Specialties
PrimaryHEMATOLOGY
Education
OTHER
Class of 1986
Research & Publications (20)
Serum BLyS levels increase after rituximab as initial therapy in patients with follicular Grade 1 non-Hodgkin lymphoma.
PMID 19051265·Am J Hematol·2009
4-observational
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group.
PMID 18543327·Cancer·2008
3-trial
Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphoma.
PMID 18281543·Clin Cancer Res·2008
3-trial
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma.
PMID 17515574·J Clin Oncol·2007
3-trial
Randomized phase II study of interleukin-12 in combination with rituximab in previously treated non-Hodgkin's lymphoma patients.
PMID 17062681·Clin Cancer Res·2006
3-trial
Antilymphoma treatments given subsequent to Yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: a review of the literature.
PMID 15636698·Clin Lymphoma·2004
6-review
Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma.
PMID 14749704·Leukemia·2004
7-preclinical
Topotecan in patients with advanced neuroendocrine tumors: a phase II study with significant hematologic toxicity.
PMID 15170140·Am J Clin Oncol·2004
3-trial
Adding cytokines to monoclonal antibody therapy: does the concurrent administration of interleukin-12 add to the efficacy of rituximab in B-cell non-hodgkin lymphoma?
PMID 12952223·Leuk Lymphoma·2003
6-review
Primer on medical genomics. Part VI: Genomics and molecular genetics in clinical practice.
PMID 12630584·Mayo Clin Proc·2003
6-review
Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma.
PMID 11756154·Blood·2002
3-trial
Subsequent chemotherapy regimens are well tolerated after radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for non-Hodgkin's lymphoma.
PMID 12228209·J Clin Oncol·2002
8-other
Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.
PMID 11157023·J Clin Oncol·2001
8-other
A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors.
PMID 11301403·Cancer·2001
3-trial
Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.
PMID 19648970·Bone Marrow Transplant·2010
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1558335935
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile